Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good morning, everybody. Thanks for joining us here. I'm Matthew Harrison, one of the biotech analysts at Morgan Stanley. Very pleased to have Editas with us for the next session. Before we get started, I just need to read a disclosure statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. We've got the full crew with us. So we have Jim Mullen, CEO; Mark Shearman, CSO; and Lisa Michaels, CMO. So very pleased to have you all here, and thanks for joining us.
Questions & Answers
I thought maybe a good place to start as you -- you recently spent some time at Cold Spring talking about some of the newer technologies that you're working on. So maybe just talk a little bit about SLEEK and why you've made some investments there and how you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |